Abstract
Hyperglycaemia is a life-threatening risk factor that occurs in both chronic and acute phases and has been linked to causing injury to many organs. Protein modification was triggered by hyperglycaemic stress, which resulted in pathogenic alterations such as impaired cellular function and tissue damage. Dysregulation in cellular function increases the condition associated with metabolic disorders, including cardiovascular diseases, nephropathy, retinopathy, and neuropathy. Hyperglycaemic stress also increases the proliferation of cancer cells. The major areas of experimental biomedical research have focused on the underlying mechanisms involved in the cellular signalling systems involved in diabetes-associated chronic hyperglycaemia. Reactive oxygen species and oxidative stress generated by hyperglycaemia modify many intracellular signalling pathways that result in insulin resistance and β-cell function degradation. The dysregulation of post translational modification in β cells is clinically associated with the development of diabetes mellitus and its associated diseases. This review will discuss the effect of hyperglycaemic stress on protein modification and the cellular signalling involved in it. The focus will be on the significant molecular changes associated with severe metabolic disorders.
Similar content being viewed by others
Data Availability
No data were used in this review article.
References
Kumar P, Swain MM, Pal A (2016) Hyperglycemia-induced inflammation caused down-regulation of 8-oxoG-DNA glycosylase levels in murine macrophages is mediated by oxidative-nitrosative stress-dependent pathways. Int J Biochem Cell Biol 73:82–98
Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycaemia. The Lancet 373(9677):1798–1807
Marik PE (2019) Endocrinology of the stress response during critical illness. Crit Care Nephrol 446–454
Zheng H, Wu J, ** Z, Yan LJ (2016) Protein modifications as manifestations of hyperglycemic glucotoxicity in diabetes and its complications. Biochem Insights 9:BCI-S36141
Parrinello CM, Lutsey PL, Couper D, Eckfeldt JH, Steffes MW, Coresh J, Selvin E (2015) Total short-term variability in biomarkers of hyperglycemia in older adults. Clin Chem 61(12):1540–1541
Juraschek SP, Steffes MW, Miller ER III, Selvin E (2012) Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care 35(11):2265–2270
Ighodaro OM (2018) Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed Pharmacother 108:656–662
Callahan LA, Supinski GS (2014) Hyperglycemia-induced diaphragm weakness is mediated by oxidative stress. Crit Care 18(3):1–17
Osawa T, Kato Y (2005) Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci 1043(1):440–451
Aronson D, Rayfield EJ (2002) How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1(1):1–10
West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17(3):171–180
Cao Y, Yang Z, Chen Y, Jiang S, Wu Z, Ding B, Yang Y, ** Z, Tang H (2021) An overview of the posttranslational modifications and related molecular mechanisms in diabetic nephropathy. Front Cell Dev Biol 9:630401
Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci 97(22):12222–12226
Kajbaf F, Mojtahedzadeh M, Abdollahi M (2007) Mechanisms underlying stress-induced hyperglycemia in critically ill patients. Clin Pract 4(1):97
**u F, Stanojcic M, Diao L, Jeschke MG (2014) Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol 2014:486403
Yan LJ (2014) Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J Diabetes Res 2014:137919
Porte D Jr, Kahn SE (1991) Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment—an update. Am J Med 90(6):S8–S14
Mirzaei F, Khodadadi I, Vafaei SA, Abbasi-Oshaghi E, Tayebinia H, Farahani F (2021) Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy. Prim Care Diabetes 15(3):409–416
Hammes HP (2018) Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia 61(1):29–38
Brown M, Tache Y, Fisher D (1979) Central nervous system action of bombesin: mechanism to induce hyperglycemia. Endocrinology 105(3):660–665
Palumbo F, Bianchi C, Miccoli R, Del Prato S (2003) Hyperglycaemia and cardiovascular risk. Acta Diabetol 40(2):s362–s369
Safi SZ, Qvist R, Yan GOS, Ismail ISB (2014) Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells. BMC Med Genomics 7(1):1–13
Hecker M, Wagner AH (2018) Role of protein carbonylation in diabetes. J Inherit Metab Dis 41(1):29–38
Wadham C, Parker A, Wang L, **a P (2007) High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes 56(11):2715–2721
Kim HJ, Lee W, Yun JM (2014) Luteolin inhibits hyperglycemia-induced proinflammatory cytokine production and its epigenetic mechanism in human monocytes. Phytother Res 28(9):1383–1391
Dehnavi S, Sadeghi M, Penson PE, Banach M, Jamialahmadi T, Sahebkar A (2019) The role of protein SUMOylation in the pathogenesis of atherosclerosis. J Clin Med 8(11):1856
Latha RCR (2014) Therapeutic potential of active principles isolated from fruits of Terminalia bellerica Roxb. in streptozotocin-induced diabetic Wistar rats
Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117(12):1610–1619
Lee PG, Halter JB (2017) The pathophysiology of hyperglycemia in older adults: clinical considerations. Diabetes Care 40(4):444–452
Ryu TY, Park J, Scherer PE (2014) Hyperglycemia as a risk factor for cancer progression. Diabetes Metab J 38(5):330–336
Wang C (2013) The relationship between type 2 diabetes mellitus and related thyroid diseases. J Diabetes Res 2013:390534
Shah NH, Velez V, Casanova T, Koch S (2014) Hyperglycemia presenting as left middle cerebral artery stroke: a case report. J Vasc Interv Neurol 7(4):9
Leal JM, de Souza GH, Marsillac PFD, Gripp AC (2022) Skin manifestations associated with systemic diseases–Part II. An Bras Dermatol 96:672–687
Villeneuve LM, Reddy MA, Natarajan R (2011) Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol 38(7):451–459
Ahmed N (2005) Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes Res Clin Pract 67(1):3–21
Chitwood DG, Wang Q, Elliott K, Bullock A, Jordana D, Li Z, Wu C, Harcum SW, Saski CA (2021) Characterization of metabolic responses, genetic variations, and microsatellite instability in ammonia-stressed CHO cells grown in fed-batch cultures. BMC Biotechnol 21(1):1–16
Ramteke P, Deb A, Shepal V, Bhat MK (2019) Hyperglycemia associated metabolic and molecular alterations in cancer risk, progression, treatment, and mortality. Cancers 11(9):1402
Srivastava SP, Goodwin JE (2020) Cancer biology and prevention in diabetes. Cells 9(6):1380
Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 137(8):e30–e66
Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10(1):88–95
American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Supplement_1):S81–S90
Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol 4:37
Quan W, Jo EK, Lee MS (2013) Role of pancreatic β-cell death and inflammation in diabetes. Diabetes Obes Metab 15(s3):141–151
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058–1070
Jayaraman A, Pike CJ (2014) Alzheimer’s disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep 14(4):1–9
Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V (2015) Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 85(13):1123–1130
Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ (2014) Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 82(13):1132–1141
Srodulski S, Sharma S, Bachstetter AB, Brelsfoard JM, Pascual C, **e XS, Saatman KE, Van Eldik LJ, Despa F (2014) Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener 9(1):1–12
Sivitz WI, Yorek MA (2010) Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12(4):537–577
Rochette L, Zeller M, Cottin Y, Vergely C (2014) Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta (BBA)-Gen Subj 1840(9):2709–2729
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14(3):168–181
Bharadwaj P, Wijesekara N, Liyanapathirana M, Newsholme P, Ittner L, Fraser P, Verdile G (2017) The link between type 2 diabetes and neurodegeneration: roles for amyloid-β, amylin, and tau proteins. J Alzheimers Dis 59(2):421–432
Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX (2013) Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis 33(2):329–338
Verdile G, Fuller SJ, Martins RN (2015) The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 84:22–38
Akhan T, Hassan I, Ahmad A, Perveen A, Aman S, Quddusi S, M Alhazza I, M Ashraf G, Aliev G (2016) Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders. CNS Neurol Disord-Drug Targets (Formerly Curr Drug Targets-CNS & Neurol Disord) 15(3):310–320
Saeed K, Shah SA, Ullah R, Alam SI, Park JS, Saleem S, Jo MH, Kim MW, Hahm JR, Kim MO (2020) Quinovic acid impedes cholesterol dyshomeostasis, oxidative stress, and neurodegeneration in an amyloid-β-induced mouse model. Oxidative Med Cell Longev 2020:9523758
Völgyi K, Háden K, Kis V, Gulyássy P, Badics K, Györffy BA, Simor A, Szabó Z, Janáky T, Drahos L, Dobolyi Á (2017) Mitochondrial proteome changes correlating with β-amyloid accumulation. Mol Neurobiol 54(3):2060–2078
Kuga GK, Botezelli JD, Gaspar RC, Gomes RJ, Pauli JR, Leme JACDA (2017) Hippocampal insulin signaling and neuroprotection mediated by physical exercise in Alzheimer´ s Disease. Motriz: Revista de Educação Física 23:e101608
Bhupathiraju SN, Hu FB (2016) Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res 118(11):1723–1735
Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI (2008) Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 4(3):261–272
Sousa AG, Selvatici L, Krieger JE, Pereira AC (2011) Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis. Rev Diabet Stud: RDS 8(2):230
Carty CL, Bůžková P, Fornage M, Franceschini N, Cole S, Heiss G, Hindorff LA, Howard BV, Mann S, Martin LW, Zhang Y (2012) Associations between incident ischemic stroke events and stroke and cardiovascular disease-related genome-wide association studies single nucleotide polymorphisms in the Population Architecture Using Genomics and Epidemiology study. Circ: Cardiovasc Genet 5(2):210–216
Coppelli A, Giannarelli R, Aragona M, Penno G, Falcone M, Tiseo G, Ghiadoni L, Barbieri G, Monzani F, Virdis A, Menichetti F, Del Prato S (2020) Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study. Diabetes Care 43(10):2345–2348
Wu J, Huang J, Zhu G, Wang Q, Lv Q, Huang Y, Yu Y, Si X, Yi H, Wang C, **ao H (2020) Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res Care 8(1):e001476
Sardu C, D’Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R (2020) Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?. Diabetes Care 43(7):1408–1415
Gianchandani R, Esfandiari NH, Ang L, Iyengar J, Knotts S, Choksi P, Pop-Busui R (2020) Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes 69(10):2048–2053
Zahedi M, Kordrostami S, Kalantarhormozi M, Bagheri M (2023) A Review of Hyperglycemia in COVID-19. Cureus 15:e37487
Geetha HS, Singh G, Sekar A, Gogtay M, Singh Y, Abraham GM, Trivedi N (2023) Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers. World J Clin Cases 11(6):1287
Barreto EA, Cruz AS, Veras FP, Martins R, Bernardelli RS, Paiva IM., ... Leiria LO (2023) COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis. Proc Natl Acad Sci 120(21):e221711912
Hassan A, Kandel RS, Mishra R, Gautam J, Alaref A, Jahan N (2020) Diabetes mellitus and Parkinson’s disease: shared pathophysiological links and possible therapeutic implications. Cureus 12:e9853
Gurreri A, Pazzaglia A (2020) Diabetic macular edema: state of art and intraocular pharmacological approaches. Diabetes Res Clin Pract pp. 375–389
Liu X, Gong Q, Yang L, Liu M, Niu L, Wang L (2020) microRNA-199a-5p regulates epithelial-to-mesenchymal transition in diabetic cataract by targeting SP1 gene. Mol Med 26(1):1–10
Zang L, Zhang D, Yao Y, Wang Y (2021) Symptomatic intracranial hemorrhage in patients with admission hyperglycemia and diabetes after mechanical thrombectomy: A systematic review and meta-analysis. Am J Emerg Med 45:23–28
Jain A, Sankhe S (2020) Hyperglycemia-induced seizures and blindness. Indian J Radiol Imaging 30(02):245–247
Gupta G, Wadhwa R, Pandey P, Singh SK, Gulati M, Sajita S, Mehta M, Singh AK, Dureja H, Collet T, Pabreja K (2020) Obesity and diabetes: pathophysiology of obesity-induced hyperglycemia and insulin resistance. Pathophysiology of obesity-induced health complications. Springer, Cham, pp 81–97
Taimour S, Gottsäter A, Jujic A, Nilsson PM (2021) Hyperglycemia and arterial stiffness across two generations. J Hypertens 39(3):471–475
Wang N, Xu P, Wu R, Wang X, Wang Y, Shou D, Zhang Y (2021) Timosaponin BII improved osteoporosis caused by hyperglycemia through promoting autophagy of osteoblasts via suppressing the mTOR/NFκB signaling pathway. Free Radical Biol Med 171:112–123
Chen C, Zhang B, Xue J, Li Z, Dou S, Chen H, Wang Q, Qu M, Wang H, Zhang Y, Wan L (2022) Pathogenic Role of Endoplasmic Reticulum Stress in Diabetic Corneal Endothelial Dysfunction. Invest Ophthalmol Vis Sci 63(3):4–4
Gayathiri R (2020) A Study on Diabetes Mellitus as a Risk Factor for Primary Open Angle Glaucoma (Doctoral dissertation, Thanjavur Medical College, Thanjavur)
Casadei G, Filippini M, Brognara L (2021) Glycated hemoglobin (HbA1c) as a biomarker for diabetic foot peripheral neuropathy. Diseases 9(1):16
Luo P, He WX, Li C, Chang MJ (2021) Enteric glial cells exert neuroprotection from hyperglycemia-induced damage via Akt/GSK3β pathway. NeuroReport 32(10):875–881
Upadhyay J, Trivedi N, Lal A (2020) Risk of future type 2 diabetes mellitus in patients develo** steroid-induced hyperglycemia during hospitalization for chronic obstructive pulmonary disease exacerbation. Lung 198(3):525–533
Zheng W, Guo J, Liu ZS (2021) Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Clin Epigenetics 13(1):1–16
Khan QA, Batool A, Haider MA, Hanif M, Khan AW (2020) A rare case of Hemichorea-Hemiballismus due to chronic uncontrolled hyperglycemia. Cureus 12(10):e10861
Svoboda SA, Shields BE (2021) Cutaneous manifestations of nutritional excess: Pathophysiologic effects of hyperglycemia and hyperinsulinemia on the skin. Cutis 107(2):74–78
Georgakis MK, Harshfield EL, Malik R, Franceschini N, Langenberg C, Wareham NJ, Markus HS, Dichgans M (2021) Diabetes mellitus, glycemic traits, and cerebrovascular disease: a Mendelian randomization study. Neurology 96(13):e1732–e1742
Du Y, Bai L, Fan B, Ding H, Ding H, Hou L, Ma H, **ng N, Wang F (2022) Effect of SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists on diabetic foot-related extremity amputation in patients with T2DM: A meta-analysis. Prim Care Diabetes 16(1):156–161
Kronfli A, Boukerche F, Medina D, Geertsen A, Patel A, Ramedani S, Lehman E, Aziz F (2021) Immediate postoperative hyperglycemia after peripheral arterial bypass is associated with short-term and long-term poor outcomes. J Vasc Surg 73(4):1350–1360
Toki T, Shimizu-Motohashi Y, Komaki H, Takeshita E, Ishiyama A, Saito T, Mori-Yoshimura M, Sumitomo N, Hirasawa-Inoue A, Nakagawa E, Nishino I (2021) Hyperglycemic crisis in patients with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Pediatr Neurol 114:1–4
Sai Laxmi M, Prabhakar O (2021) Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy. J Diabetes Metab Disord 20(1):869
Jubaidi FF, Zainalabidin S, Taib IS, Hamid ZA, Budin SB (2021) The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis. Int J Mol Sci 22(10):5094
Kim YE, Lee M, Lee YH, Kang ES, Cha BS, Lee BW (2021) Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes. Diabetes Res Clin Pract 181:109082
Acknowledgements
Hamda Khan is highly thankful to the DS Kothari Fellowship (DSK-PDF) Award No. F.4-2/2006 (BSR)/BL/20-21/0373 for providing fellowship as Post Doctoral Fellow.
Funding
The authors are thankful to the UGC-DS Kothari Fellowship (DSKPDF) scheme (No.F.4–2/2006 (BSR)/BL/20–21/0373), New Delhi for providing financial assistance to Dr. Hamda Khan in the form post doctoral fellowship.
Author information
Authors and Affiliations
Contributions
H. Khan and A. Khanam contributed in writing. A. A. Khan, R. Ahmad, and A. Husain done editing. S. Habib, S. Ahmad, and Moinuddin organized the structure of review.
Corresponding author
Ethics declarations
Ethical Approval
Not applicable.
Consent to Participate
Not applicable.
Consent to Publish
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Khan, H., Khanam, A., Khan, A.A. et al. The complex landscape of intracellular signalling in protein modification under hyperglycaemic stress leading to metabolic disorders. Protein J 43, 425–436 (2024). https://doi.org/10.1007/s10930-024-10191-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-024-10191-3